Ceribell (CBLL) Net Cash Flow (2023 - 2026)
Ceribell (CBLL) posted Net Cash Flow of $4.8 million for Q1 2026, down 71.46% on a QoQ basis from $16.7 million in Q4 2025, and up 111.65% year-over-year from $2.3 million in Q1 2025.
Ceribell (CBLL) Net Cash Flow (2023 - 2026) Analysis & Trends
Ceribell's Net Cash Flow history runs 4 years deep, the most recent figure standing at $4.8 million for Q1 2026.
- Quarterly Net Cash Flow rose 111.65% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$108.1 million (down 189.44% YoY) and the FY2025 annual result came in at -$153.9 million, down 196.26% from the prior year.
- Net Cash Flow was $4.8 million for Q1 2026 at Ceribell, down from $16.7 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $180.3 million in Q4 2024 and bottomed at -$113.2 million in Q2 2025.
- A 4-year average of -$6300.0 and a median of -$9.2 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow surged 1765.99% — and 2025, when it sank 1946.41%.
- Ceribell's Net Cash Flow stood at -$10.8 million in 2023, then jumped by 1765.99% to $180.3 million in 2024, then sank by 90.72% to $16.7 million in 2025, then tumbled by 71.46% to $4.8 million in 2026.
- Business Quant data shows CBLL's Net Cash Flow at $4.8 million in Q1 2026, $16.7 million in Q4 2025, and -$16.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | 4.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.78 Mn |
| Mar 31, 2026 | 4.78 Mn |
| Dec 31, 2025 | 16.74 Mn |
| Dec 31, 2025 | 16.74 Mn |
| Sep 30, 2025 | -16.40 Mn |
| Sep 30, 2025 | -16.40 Mn |
| Jun 30, 2025 | -113.22 Mn |
| Jun 30, 2025 | -113.22 Mn |
| Mar 31, 2025 | -41.01 Mn |
| Mar 31, 2025 | -41.01 Mn |
| Dec 31, 2024 | 180.26 Mn |
| Dec 31, 2024 | 180.26 Mn |
| Sep 30, 2024 | -10.25 Mn |
| Sep 30, 2024 | -10.25 Mn |
| Jun 30, 2024 | -8.13 Mn |
| Jun 30, 2024 | -8.13 Mn |
| Mar 31, 2024 | -2.00 Mn |
| Mar 31, 2024 | -2.00 Mn |
| Dec 31, 2023 | -10.82 Mn |
| Dec 31, 2023 | -10.82 Mn |